Every year, at the European Cancer Summit, the European Cancer Organisation brings together leading oncology experts, experienced patient advocates, key opinion leaders, policy makers and politicians to discuss key issues in reducing the burden of cancer, saving, and improving the lives of patients and the public.
This year’s European Cancer Summit on 16-17 November will focus on the implementation of Europe’s Beating Cancer Plan and the EU Cancer Mission’s recommendations, including through our ten Focused Topic Networks.
We are planning this year’s Summit as a hybrid event with the majority of speakers and delegates meeting face-to-face in Brussels and others able to join virtually, bringing together the European cancer community including our Member Societies and Patient Advocacy groups.
The European Cancer Summit is a key event in the cancer policy calendar. Our goal is to showcase the multi-stakeholder, collaborative efforts being made, to ensure tangible results. We believe this exchange will help to improve outcomes for cancer patients and raise awareness of the many significant challenges of cancer.
View the highlights video from the hybrid 2021 European Cancer Summit and read the report.
We already have leading speakers and panellists confirmed and you can see who will be joining us "on stage" here.
The European Cancer Summit 2022 Programme co-chairs Ajay Aggarwal and Gilliosa Spurrier-Bernard are guiding the development of an impactful programme with leading speakers and will have more news to share in the coming months.
View the preliminary programme here.
With the support of visit.brussels and the Brussels-Capital Region
We invite everyone interested in attending the European Cancer Summit 2022 to register below.
For delegates planning to come to Brussels, we have secured preferential accommodation rates/conditions in the Summit hotel for delegates joining us at the Summit venue ‘Radisson Collection Hotel, Grand Place Brussels’. For the best available rates and booking conditions, please click here. Enter the dates of your stay, and within the special rate drop-down menu, enter the SUMMIT22 promotional code received upon registration. Please note that the European Cancer Organisation is not responsible for any travel, hotel or cancellation costs .
Please be aware that the special rate is only available until 15 September.
Cancelled registrations are not refundable, but can be eligible for a change of name for €175. Please contact us if you have any questions.
With Andreas Charalambous, European Cancer Organisation's President, Ajay Aggarwal and Gilly Spurrier-Bernard, European Cancer Summit 2022 Co-Chairs
With Network Co-Chairs Nicolò Matteo Luca Battisti and Hendrik Van Poppel
With Network Co-Chair Csaba Dégi
With Network Co-Chairs Simon Oberst and Fedro Peccatori
With Network Co-Chairs Mirjam Crul, Wendy Oldenmenger and Beate Rau
With Network Co-Chairs Andreas Charalambous, President, and Eric Winer, American Society of Clinical Oncology's President, including speakers:
With Andreas Charalambous, President, including speakers:
Alex Eniu, Deputy Scientific Director, European School of Oncology (ESO)
With Prevention, Early Detection and Screening Network Co-Chairs Isabel Teresa Rubio and Jan van Meerbeeck.
2022 is a landmark year in the lifespan of Europe’s Beating Cancer Plan, especially in respect to its early detection and screening pillar. In March 2022, the latest scientific advice was prepared and issued to the European Commission to inform a long overdue update of the official EU recommendations to its Member States on cancer screening. Notably, scientific advisors saw positive reasons to consider including advice to member states to lung, prostate and gastric cancer screening, alongside the already existing advice to countries on breast, cervical and colorectal cancer screening.
The session will hear from those most closely involved in the advisory process, and consider additional matters such as the implementation journey ahead for the new EU cancer screening recommendations, and how early detection needs more generally for cancer can be met through coordinated policy interventions beyond screening.
With Network Co-Chairs Mirjam Crul and Mark Lawler, including speakers:
With Andreas Charalambous, President, and Ajay Aggarwal, Summit Co-Chair, including speakers:
And the best authors of chosen abstracts will also take part in this session.
With Network Co-Chairs Denis Lacombe and Yolande Lievens, including speakers:
With Network Co-Chairs Daniel Kelly and Rui Medeiros, including speakers:
With Network Co-Chairs Carlo Catalano and Wim Oyen
With Andreas Charalambous, President
The European Cancer Organisation is committed to delivering equitable and effective cancer care globally, translating the best evidence to policy and practice. We welcome research abstracts which fit within our key Focused Topic Networks and priority areas within Europe’s Beating Cancer Plan and the EU Cancer Mission recommendations.
This includes research into:
We have a limit on the number of abstracts that we can accept for poster and oral presentation during the Summit. Abstracts will be chosen to ensure representation across all the Focused Topic Networks and the lead author will receive free registration to the Summit, although it is not mandatory to attend. The accepted abstracts will also be published in the Journal of Cancer Policy.
We particularly encourage lead author submissions from junior clinical and academic faculty as the presentations will form part of a special session of the Summit with young cancer professionals and leaders at the Summit on Day 2. Please note that there is no abstract submission fee.
The abstract should be a maximum of 350 words in length (excluding references). Please present the following subheadings:
Up to one figure or table will be accepted and a maximum of three references.
Please promote this opportunity to your members and contacts.
Those interested in submitting an abstract are asked to send an email expressing their interest to summitabstract@europeancancer.org as soon as possible, including the focused topic that they are interested in, and they will then receive further details.
The final abstract should be submitted by 1 September 2022 to the same email address. Notification of successful abstracts will be announced to authors before the end of September 2022.